261 Association of T-cell–inflamed gene expression profile and PD-L1 status with efficacy of pembrolizumab in patients with esophageal cancer from KEYNOTE-180

• Takashi Kojima,
• Sung-Bae Kim,
• Ken Kato,
• Antoine Hollebecque,
• Per Pfeiffer,
• Florian Lordick,
• Masahiro Tajika,
• Mark Ayers,
• Jared Lunceford,
• Manish Shah,
• Daniel Hochhauser,
• Peter Enzinger,
• Judith Raimbourg,
• Heung Tae Kim,
• A Craig Lockhart,
• Hendrick-Tobias Arkenau,
• Farid El-Hajbi,
• Pooja Bhagia,
• Z Alexander Cao,
• Shailaja Suryawanshi,
• Matt Marton

Affiliations

Takashi Kojima

1 Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan

Sung-Bae Kim

8Asan Medical Center, Seoul, Korea, Republic of

Ken Kato

16National Cancer Center Hospital, Tokyo, Japan

Antoine Hollebecque

Drug Development Department, Gustave Roussy, Villejuif, France

Per Pfeiffer

14Odense University Hospital, Odense, Denmark

Florian Lordick

7University Cancer Center Leipzig, Leipzig, Germany

Masahiro Tajika

9Aichi Cancer Center Hospital, Aichi, Japan

Mark Ayers

Aff218 grid.417993.10000000122600793Merck & Co., Inc. West Point PA USA

Jared Lunceford

Aff244 grid.417993.10000000122600793Merck & Co., Inc. Kenilworth NJ USA

Manish Shah

1Weill Cornell Medical College, New York, NY, USA

Daniel Hochhauser

3University College London Hospitals, London, UK

Peter Enzinger

4Dana-Farber Cancer Institute, Boston, MA, USA

Judith Raimbourg

5Institut de Cancérologie de l’Ouest, St Herblain, France

Heung Tae Kim

10National Cancer Center, Goyang, Korea, Republic of

A Craig Lockhart

11University of Miami, Miami, FL, USA

Hendrick-Tobias Arkenau

12Sarah Cannon Research Institute, London, UK

Farid El-Hajbi

13Centre Oscar-Lambret, Lille, France

Pooja Bhagia

15Merck and Co., Inc., Kenilworth, NJ, USA

Z Alexander Cao

15Merck and Co., Inc., Kenilworth, NJ, USA

Shailaja Suryawanshi

15Merck and Co., Inc., Kenilworth, NJ, USA

Matt Marton

15Merck and Co., Inc., Kenilworth, NJ, USA